About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

ORBITA: What Goes Around, Comes Around… Or Does It?

Citation:

Interventional Cardiology Review 2018;13(3):135–6.

Anticoagulation in Patients with Ischaemic Heart Disease and Peripheral Arterial Disease: Clinical Implications of COMPASS study

Citation:

European Cardiology Review 2018;13(2):115–8.

Using Pharmacogenetic Testing or Platelet Reactivity Testing to Tailor Antiplatelet Therapy: Are Asians Different from Caucasians?

Citation:

European Cardiology Review 2018;13(2):112–4.

Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease

Citation:

US Cardiology Review 2019;13(1):16–20